Drug Type CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism LILRA6 modulators(leukocyte immunoglobulin like receptor A6 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Recurrent Acute Leukemia | Phase 1 | China | 01 Dec 2025 | |
| Refractory acute myeloid leukemia | Phase 1 | China | 01 Dec 2025 |





